Singular Genomics Systems Inc (OMIC)
Singular Genomics Systems Inc (OMIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,620 | 30,115 | 24,109 | 16,233 | 33,301 |
| Marketable Securities | 61,213 | 103,089 | 126,629 | 157,708 | 157,416 |
| Receivables | 183 | 440 | 137 | 565 | 399 |
| Inventories | 12,410 | 12,442 | 13,081 | 13,572 | 13,420 |
| TOTAL | $129,810 | $148,695 | $166,475 | $192,228 | $210,795 |
| Non-Current Assets | |||||
| PPE Net | 12,457 | 13,249 | 13,854 | 13,692 | 13,426 |
| Other Non-Current Assets | 44,284 | 58,059 | 58,772 | 59,547 | 60,297 |
| TOTAL | $56,741 | $71,308 | $72,626 | $73,239 | $73,723 |
| Total Assets | $186,551 | $220,003 | $239,101 | $265,467 | $284,518 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,882 | 1,498 | 2,012 | 2,587 | 2,432 |
| Accrued Expenses | 4,887 | 4,049 | 3,265 | 6,079 | 5,063 |
| Other current liabilities | 5,371 | 4,335 | 2,980 | 1,857 | 252 |
| TOTAL | $17,609 | $16,947 | $16,079 | $18,287 | $15,453 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,166 | 6,355 | 7,627 | 8,901 | 10,175 |
| Other Non-Current Liabilities | 40,523 | 58,994 | 58,697 | 59,273 | 59,863 |
| TOTAL | $45,689 | $65,349 | $66,324 | $68,174 | $70,038 |
| Total Liabilities | $63,298 | $82,296 | $82,403 | $86,461 | $85,491 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,512 | 2,496 | 2,467 | 2,462 | 2,444 |
| Common Shares | N/A | N/A | 7 | 7 | 7 |
| Retained earnings | -400,668 | -383,873 | -362,619 | -337,595 | -314,346 |
| Other shareholders' equity | 83 | -74 | -51 | 155 | -214 |
| TOTAL | $123,253 | $137,707 | $156,698 | $179,006 | $199,027 |
| Total Liabilities And Equity | $186,551 | $220,003 | $239,101 | $265,467 | $284,518 |